BindingDB logo
myBDB logout

50 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
8360878 29 Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
8360871 86 Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carEBI Warner-Lambert Company
8515425 65 Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.EBI SmithKline Beecham Pharmaceuticals
1875338 7 Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties.EBI Searle R&D and MCR
1875348 65 Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.EBI E. I. du Pont de Nemours& Company, Inc.
1956044 115 Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.EBI Warner Lambert Company
2329554 20 Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.EBI E. I. du Pont de Nemours and Co., Inc.
2329553 81 The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.EBI E. I. du Pont de Nemours& Company, Inc.
2704034 16 Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.EBI Washington State University
27004954 8 Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs.EBI Donghua University
25699147 6 Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.EBI Uppsala University
19013821 12 Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.EBI Punjabi University
18158200 10 Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.EBI Punjabi University
20073471 15 Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.EBI The University of Mississippi
18318468 39 Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.EBI Universit£ di Siena
8410980 8 2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.EBI Abbott Laboratories
 54 4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridines: potent arylacetic acid-derived AT1 antagonists with improved affinity for the AT2 receptorEBI TBA
 42 Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureasEBI TBA
 60 The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptorsEBI TBA
 19 2,3,6-Substituted quinazolinones as angiotensin II receptor antagonistsEBI TBA
 56 Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypesEBI TBA
 134 Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.EBI TBA
 46 Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinitiesEBI TBA
 10 Synthesis and biological evaluation of the potent isoxazolidinyl angiotensin II receptor antagonist CL332,877 and its enantiomers.EBI TBA
 34 6-isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonistsEBI TBA
18599297 50 Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.EBI Uppsala University
17825570 32 Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.EBI Uppsala University
12643919 50 Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.EBI Bristol-Myers Squibb Pharmaceutical Research Institute
10579820 4 Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT(1) receptor.EBI Laboratoires Fournier S.A.
8515427 43 Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.EBI Washington University School of Medicine
8258820 47 A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.EBI DuPont Merck Pharmaceutical Co.
2362273 16 Conformational restriction of angiotensin II: cyclic analogues having high potency.EBI G. D. Searle and Company
1433195 55 Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.EBI SmithKline Beecham Pharmaceuticals
25665518 18 2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H.BDB Kurukshetra University